NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe



RCPI report calls for raise of minimum age to buy tobacco products

By Reporter - 12th Sep 2022

Foróige member, Coady O’Reilly (16); Chair RCPI Policy Group on Tobacco, Prof Des Cox; Foróige member, Divine Ikharo (15)

A new report from the RCPI policy group on tobacco is calling for the minimum age of sale of tobacco to be raised from 18 to 21.

Launched 12 September, the Tobacco 21 Report was developed from national and international evidence analysed by the Institute of Public Health. The report by the RCPI policy group says amending legislation to raise the minimum legal age for the sale of tobacco products in Ireland offers a proven approach to significantly reduce the number of teenagers and young adults becoming addicted to tobacco.

“After decades of progress, tobacco control is stagnating and we are actually seeing an uptick in use among teenage boys,” said Prof Des Cox, Chair of the RCPI policy group on tobacco.

“We are not going to achieve the nationwide target of reducing smoking to 5 per cent by 2025 with the policies currently in place. Tobacco 21 is a simple and effective step on the road to tobacco endgame. It requires only simple amendments to existing legislation and has strong public support.”

“Most smokers start to smoke in their teenage years, but the age at which they are starting is rising over time. The earlier a young person starts smoking the more likely they are to become addicted and the harder it can be to quit,” he added. “Tobacco 21 will help to delay the initiation of tobacco use and, in turn, reduce the number of people who smoke.”

The RCPI report examined the implementation, public awareness and enforcement measures required to effectively roll out Tobacco 21. International modelling suggests that Tobacco 21 policies can reduce smoking rates by up to 25 per cent among 15-17-year-olds and by up to 15 per cent among 18-20-year-olds.

“On top of associations between early first use and lifetime smoking, most teenagers report finding it easy to get cigarettes directly at the shop or through friends,” said Professor Cox, who is also a consultant in paediatric respiratory medicine.

“Experimentation with smoking is highest between 15 and 17, but this cohort are less likely to have access to peer networks over 21 who could purchase for them. Tobacco 21 provides this important barrier and is vital to increasing the age of smoking initiation and the lifelong negative health impacts that come with it.”

A May 2022 HSE survey, ‘Bringing the Tobacco Epidemic to an End: Public Views on “Tobacco Endgame” in Ireland‘, also shows that 71 per cent of the population aged 15 years and older are in favour of increasing the minimum legal age for tobacco sale to 21. Additionally, 59 per cent of current smokers and 64 per cent of those who use tobacco products surveyed support the proposed policy change.

“Ireland has led in this space before,” Prof Cox added. “Innovative policies such as smoke-free workplaces in 2004 and standardised packaging in 2018 have been effective but we need more ambitious measures to save lives. This is an opportunity for Ireland to once again be a European and global leader in tobacco control.”

Nearly 4,500 people die in Ireland each year from the effects of smoking – the single biggest contributor to early death. Thousands more suffer from smoking-related diseases, including heart and lung disease, and cancers.

Tobacco products kill one in every two people. Tobacco 21 won’t change this risk for smokers, but it can reduce the numbers of people becoming tobacco-dependent and exposed to tobacco harm in the long term.

For help and support to quit smoking visit 

Leave a Reply






Latest Issue
Medical Independent 5th March
The Medical Independent 5th March 2024

You need to be logged in to access this content. Please login or sign up using the links below.


Most Read